A Japanese Dose of Prasugrel versus a Standard Dose of Clopidogrel in Patients with Acute Myocardial Infarction from the K-ACTIVE Registry.
Hiroyoshi MoriTakuya MizukamiAtsuo MaedaKazuki FukuiYoshihiro Johnny AkashiJunya AkoYuji IkariToshiaki EbinaKouichi TamuraAtsuo NamikiIchiro MichishitaKazuo KimuraHiroshi SuzukiPublished in: Journal of clinical medicine (2022)
A Japanese dose of prasugrel was commonly used in AMI patients in the real-world database. Both the prasugrel and clopidogrel groups showed comparable rates of 1 year ischemic and bleeding events.
Keyphrases
- percutaneous coronary intervention
- acute myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery disease
- end stage renal disease
- atrial fibrillation
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- heart failure
- ischemia reperfusion injury
- electronic health record